{
  "News": [
    {
      "id": 0,
      "title": "LUPIN POSITIVE FACTS DURING A COVID-19 PANDEMIC",
      "description": " Lupin has received an Establishment Inspection Report (EIR) from the USFDA for its manufacturing plant in Nagpur, Aurangabad and Mandideep with no action indicated.  Lupin has launched generic Mycophenolic acid delayed-release tablets of 180 mg and 360 mg. It is used to prevent organ rejection in patients receiving kidney transplants in the US market. ",
      "imageUrl": "https://www.dsij.in/Portals/0/EasyDNNNews/12279/600600p10163EDNmainimg-img-Lupin.jpg"
    }
  ]
}
